1. Home
  2. IPSC vs FCBM Comparison

IPSC vs FCBM Comparison

Compare IPSC & FCBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

N/A

Current Price

$1.92

Market Cap

367.6M

Sector

Health Care

ML Signal

N/A

Logo First Carolina Financial Services Inc.

FCBM

First Carolina Financial Services Inc.

N/A

Current Price

$12.94

Market Cap

393.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IPSC
FCBM
Founded
2019
N/A
Country
United States
Employees
78
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.6M
393.3M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
IPSC
FCBM
Price
$1.92
$12.94
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$4.25
N/A
AVG Volume (30 Days)
386.4K
84.0K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
91.30
N/A
EPS
N/A
0.44
Revenue
$109,164,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$28.70
Revenue Growth
1556.76
N/A
52 Week Low
$0.44
$12.17
52 Week High
$2.97
$13.40

Technical Indicators

Market Signals
Indicator
IPSC
FCBM
Relative Strength Index (RSI) 41.74 58.50
Support Level $1.92 $12.50
Resistance Level $2.39 $12.92
Average True Range (ATR) 0.10 0.24
MACD -0.01 0.02
Stochastic Oscillator 7.35 77.08

Price Performance

Historical Comparison
IPSC
FCBM

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

About FCBM First Carolina Financial Services Inc.

First Carolina Financial Services Inc is a bank holding company. The company's activities consist of managing and owning the Bank and its direct and indirect subsidiaries. The Bank provides commercial banking, payment, consumer banking, and wealth management services to small and medium-sized businesses, individuals, professionals, as well as institutions of higher education. It has four primary lines of business: Commercial Banking, Payments, Consumer Banking and Wealth Management. The reportable segments are Community Banking and BM Tech. The majority of revenue is derived from the Community Banking segment, which comprises activities of a traditional banking institution, gathering deposits and originating loans for portfolio in its respective primary market areas.

Share on Social Networks: